These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 15514428)

  • 1. Estradiol effects on the postmenopausal brain.
    Moses-Kolko EL; Meltzer CC; Greer P; Butters M; Berga SL; Smith G; Drevets WC
    Am J Psychiatry; 2004 Nov; 161(11):2136; author reply 2136. PubMed ID: 15514428
    [No Abstract]   [Full Text] [Related]  

  • 2. Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women.
    Kugaya A; Epperson CN; Zoghbi S; van Dyck CH; Hou Y; Fujita M; Staley JK; Garg PK; Seibyl JP; Innis RB
    Am J Psychiatry; 2003 Aug; 160(8):1522-4. PubMed ID: 12900319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Widespread increases of cortical serotonin type 2A receptor availability after hormone therapy in euthymic postmenopausal women.
    Moses-Kolko EL; Berga SL; Greer PJ; Smith G; Cidis Meltzer C; Drevets WC
    Fertil Steril; 2003 Sep; 80(3):554-9. PubMed ID: 12969697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous plasma estradiol in healthy men is positively correlated with cerebral cortical serotonin 2A receptor binding.
    Frokjaer VG; Erritzoe D; Juul A; Nielsen FA; Holst K; Svarer C; Madsen J; Paulson OB; Knudsen GM
    Psychoneuroendocrinology; 2010 Oct; 35(9):1311-20. PubMed ID: 20356681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging.
    Rosier A; Dupont P; Peuskens J; Bormans G; Vandenberghe R; Maes M; de Groot T; Schiepers C; Verbruggen A; Mortelmans L
    Psychiatry Res; 1996 Nov; 68(1):11-22. PubMed ID: 9027929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased prefrontal 5-HT2A receptor binding in subjects at enhanced risk for schizophrenia.
    Hurlemann R; Boy C; Meyer PT; Scherk H; Wagner M; Herzog H; Coenen HH; Vogeley K; Falkai P; Zilles K; Maier W; Bauer A
    Anat Embryol (Berl); 2005 Dec; 210(5-6):519-23. PubMed ID: 16187138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased hippocampal 5-HT(2A) receptor binding in older depressed patients using [18F]altanserin positron emission tomography.
    Sheline YI; Mintun MA; Barch DM; Wilkins C; Snyder AZ; Moerlein SM
    Neuropsychopharmacology; 2004 Dec; 29(12):2235-41. PubMed ID: 15367923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of estradiol versus estradiol and testosterone on brain-activation patterns in postmenopausal women.
    Archer JS; Love-Geffen TE; Herbst-Damm KL; Swinney DA; Chang JR
    Menopause; 2006; 13(3):528-37. PubMed ID: 16735951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility of 5-HT2A receptor measurements and sample size estimations with [18F]altanserin PET using a bolus/infusion approach.
    Haugbøl S; Pinborg LH; Arfan HM; Frøkjaer VM; Madsen J; Dyrby TB; Svarer C; Knudsen GM
    Eur J Nucl Med Mol Imaging; 2007 Jun; 34(6):910-5. PubMed ID: 17195073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.
    Smith GS; Price JC; Lopresti BJ; Huang Y; Simpson N; Holt D; Mason NS; Meltzer CC; Sweet RA; Nichols T; Sashin D; Mathis CA
    Synapse; 1998 Dec; 30(4):380-92. PubMed ID: 9826230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei.
    Adams KH; Hansen ES; Pinborg LH; Hasselbalch SG; Svarer C; Holm S; Bolwig TG; Knudsen GM
    Int J Neuropsychopharmacol; 2005 Sep; 8(3):391-401. PubMed ID: 15801987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motion artifact reduction on parametric PET images of neuroreceptor binding.
    Herzog H; Tellmann L; Fulton R; Stangier I; Rota Kops E; Bente K; Boy C; Hurlemann R; Pietrzyk U
    J Nucl Med; 2005 Jun; 46(6):1059-65. PubMed ID: 15937320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A database of [(18)F]-altanserin binding to 5-HT(2A) receptors in normal volunteers: normative data and relationship to physiological and demographic variables.
    Adams KH; Pinborg LH; Svarer C; Hasselbalch SG; Holm S; Haugbøl S; Madsen K; Frøkjaer V; Martiny L; Paulson OB; Knudsen GM
    Neuroimage; 2004 Mar; 21(3):1105-13. PubMed ID: 15006678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low frontal serotonin 2A receptor binding is a state marker for schizophrenia?
    Rasmussen H; Frokjaer VG; Hilker RW; Madsen J; Anhøj S; Oranje B; Pinborg LH; Glenthøj B; Knudsen GM
    Eur Neuropsychopharmacol; 2016 Jul; 26(7):1248-50. PubMed ID: 27179966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of hormone replacement therapy on cerebral serotonin-1A receptor binding in postmenopausal women examined with [carbonyl-¹¹C]WAY-100635.
    Kranz GS; Rami-Mark C; Kaufmann U; Baldinger P; Hahn A; Höflich A; Savli M; Stein P; Wadsak W; Mitterhauser M; Winkler D; Lanzenberger R; Kasper S
    Psychoneuroendocrinology; 2014 Jul; 45():1-10. PubMed ID: 24845171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transdermal estradiol--the possibility for replacement therapy in the postmenopause].
    Rachev E
    Akush Ginekol (Sofiia); 1994; 33(3):45-7. PubMed ID: 7793531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Basic principles of hormone replacement therapy in the postmenopause].
    Dören M
    Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of brain 5HT2 receptor binding potential with a single-dose PET paradigm.
    Petit Taboué MC; Baron JC
    Eur J Nucl Med; 1995 Jun; 22(6):585-6. PubMed ID: 7556308
    [No Abstract]   [Full Text] [Related]  

  • 19. Different effects of oral and transdermal estrogen replacement therapy on matrix metalloproteinase and their inhibitor in postmenopausal women.
    Wakatsuki A; Ikenoue N; Shinohara K; Watanabe K; Fukaya T
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1948-9. PubMed ID: 14555643
    [No Abstract]   [Full Text] [Related]  

  • 20. Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder.
    Frokjaer VG; Mortensen EL; Nielsen FA; Haugbol S; Pinborg LH; Adams KH; Svarer C; Hasselbalch SG; Holm S; Paulson OB; Knudsen GM
    Biol Psychiatry; 2008 Mar; 63(6):569-76. PubMed ID: 17884017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.